The epidermal growth factor receptor (EGFR) is one of the most frequently mutated driver oncogenes in non-small cell lung cancer (NSCLC), and EGFR mutation is found in approximately 50% of the Southeast Asian lung adenocarcinoma population (1). This evidence concerns the gene EGFR and non-small cell lung carcinoma.